Paper229941
Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
MacGregor GA and 3 others. Br Med J, 1979. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme. Papers, record 229941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/229941
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Captopril | Major topic |
| Hypertension | Major topic |
| Proline | Major topic |
| Adult | |
| Aged | |
| Angiotensin-Converting Enzyme Inhibitors | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Renin |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 232490 | Converting enzyme inhibition with an orally active compound in hypertensive man. | Hypertension | 1979 | https://conductscience.org/library/papers/232490 | PubMed |
| 2 | 66571 | A specific orally active inhibitor of angiotensin-converting enzyme in man. | Lancet | 1977 | https://conductscience.org/library/papers/66571 | PubMed |
| 3 | 205788 | Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. | N Engl J Med | 1978 | https://conductscience.org/library/papers/205788 | PubMed |
| 4 | 195203 | Accentuated vascular and endocrine response to SQ 20881 in hypertension. | N Engl J Med | 1977 | https://conductscience.org/library/papers/195203 | PubMed |
| 5 | 191908 | Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. | Science | 1977 | https://conductscience.org/library/papers/191908 | PubMed |
| 6 | 185903 | Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. | Am J Med | 1976 | https://conductscience.org/library/papers/185903 | PubMed |
| 7 | 679493 | Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. | Clin Chim Acta | 1978 | https://conductscience.org/library/papers/679493 | PubMed |
| 8 | 837471 | Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects. | Circ Res | 1977 | https://conductscience.org/library/papers/837471 | PubMed |
| 9 | 973974 | Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/973974 | PubMed |
| 10 | 1103909 | Clinical experience with use of ultrasound sphygmomanometer. | Br Heart J | 1975 | https://conductscience.org/library/papers/1103909 | PubMed |
| 11 | 1245602 | Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man. | J Clin Invest | 1976 | https://conductscience.org/library/papers/1245602 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8597776 | How adverse drug reactions can play a role in innovative drug research. | Pharm World Sci | 1995 | https://conductscience.org/library/papers/8597776 | PubMed |
| 8198936 | Dose finding studies with imidapril--a new ACE inhibitor. | Br J Clin Pharmacol | 1994 | https://conductscience.org/library/papers/8198936 | PubMed |
| 7946796 | ACE inhibitors for heart failure: a question of dose. | Br Heart J | 1994 | https://conductscience.org/library/papers/7946796 | PubMed |
| 7026256 | Haemodynamic profile of captopril treatment in various forms of hypertension. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7026256 | PubMed |
| 7009133 | Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. | Drugs | 1980 | https://conductscience.org/library/papers/7009133 | PubMed |
| 6802291 | Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6802291 | PubMed |
| 6758826 | Heart rate control in hypertensive patients treated by captopril. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6758826 | PubMed |
| 6387264 | Captopril in Cushing's syndrome. | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6387264 | PubMed |
| 6308066 | Angiotensin-converting enzyme and its clinical significance--a review. | J Clin Pathol | 1983 | https://conductscience.org/library/papers/6308066 | PubMed |
| 6282372 | Relation of plasma renin activity to the antihypertensive effect of MK 421 in the rat. | Br J Pharmacol | 1982 | https://conductscience.org/library/papers/6282372 | PubMed |
| 6266576 | Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6266576 | PubMed |
| 6259406 | Captopril in various forms of severe therapy-resistant hypertension. | Klin Wochenschr | 1981 | https://conductscience.org/library/papers/6259406 | PubMed |
| 6159943 | Inhibitors of angiotensin I converting enzyme for treating hypertension. | Br Med J | 1980 | https://conductscience.org/library/papers/6159943 | PubMed |
| 3886905 | Captopril for refractory hypertension in patients with impaired renal function. | J R Soc Med | 1985 | https://conductscience.org/library/papers/3886905 | PubMed |
| 3520132 | Minoxidil and captopril in severe hypertension. | Klin Wochenschr | 1986 | https://conductscience.org/library/papers/3520132 | PubMed |
| 3103761 | Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study. | Br Med J (Clin Res Ed) | 1987 | https://conductscience.org/library/papers/3103761 | PubMed |
| 2537217 | Safety and tolerance of single oral doses of trandolapril (RU 44.570), a new angiotensin converting enzyme inhibitor. | Eur J Clin Pharmacol | 1989 | https://conductscience.org/library/papers/2537217 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE | 1636 | PubTator's text mining | https://conductscience.org/library/genes/1636 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/229941
GET https://conductscience.org/api/papers/v1/229941/authors